Phase III AXIS trial of axitinib versus sorafenib in metastatic renal cell carcinoma: Updated results among cytokine-treated patients Meeting Abstract


Authors: Michaelson, M. D.; Rini, B. I.; Escudier, B. J.; Clark, J.; Redman, B.; Tarazi, J. C.; Rosbrook, B.; Kim, S.; Motzer, R. J.
Abstract Title: Phase III AXIS trial of axitinib versus sorafenib in metastatic renal cell carcinoma: Updated results among cytokine-treated patients
Meeting Title: 48th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 30
Issue: 15 Suppl.
Meeting Dates: 2012 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2012-05-20
Language: English
ACCESSION: WOS:000318009803341
PROVIDER: wos
DOI: 10.1200/jco.2012.30.15_suppl.4546
Notes: Meeting Abstract: 4546 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer